• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    DDC Enterprise Limited and Ace Global Business Acquisition Limited Announce Initial Filing of Preliminary Proxy Statement in Connection with Proposed Business Combination and the Appointment of Independent Directors and Advisor

    11/8/21 8:00:00 AM ET
    $ACBA
    $EH
    $IMAB
    $TOUR
    Catalog/Specialty Distribution
    Consumer Discretionary
    Aerospace
    Industrials
    Get the next $ACBA alert in real time by email

    NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- DDC Enterprise Limited (the "Company" or "DDC"), a digital publisher and merchandising company that owns and operates the brand DayDayCook, and Ace Global Business Acquisition Limited ("Ace") (NASDAQ:ACBA, ACBAU, ACBAW))), a special purpose acquisition company ("SPAC"), announced today that Ace has filed a preliminary proxy statement with the U.S. Securities and Exchange Commission ("SEC") in connection with the previously announced business combination transaction between DDC and Ace . (the "Business Combination").

    While the information in the filed preliminary proxy statement is subject to change, it provides important information about Ace's proposed Business Combination with DDC. Ace currently anticipates holding a shareholder meeting with respect to the transactions contemplated by the Business Combination in the fourth quarter of 2021.

    As previously announced on August 25, 2021, upon the closing of the transactions contemplated by the Business Combination, the parties plan to remain Nasdaq-listed under a new ticker symbol. As part of the agreement, DDC will keep its highly experienced management team in place, which is led by Norma Chu, DDC's Founder and CEO, and will spearhead the Company's strategic transformation. As part of the transaction, DDC and Ace will aim to raise private investment in public equity (PIPE) of approximately US$30-40 million, which will be used to fund DDC's growth plans.

    DDC – A Leader in Food Innovation

    Founded in 2012, DDC is a digital publisher and merchandising company that owns and operates the brand DayDayCook, which is currently one of the leading content-driven lifestyle brands for young food lovers located in Asian markets.

    DDC has launched ready-to-heat (RTH), ready-to-cook (RTC) and plant-based food products, which bring convenience and quality food products to the young food lovers. DDC, together with its subsidiaries (the "Group"), builds brand recognition through culinary and lifestyle content across major social media and e-commerce platforms to promote its products, which, in the aggregate, has resulted in over 3 billion video views and more than 10 million orders worldwide.

    As of the second fiscal quarter of 2021, DDC has had 60 million active viewers and 3.4 million paid customers. Of the 60 million active viewers, approximately 85% are Generation Z, 75% are from non-tier 1 cities in China, and 62% are female. The average age of a viewer engaging with DDC's products or marketplace is under 30 years old. DDC also has a content library with more than 473,000 minutes of in-house created content. For the six month period ended 30 June 2021 ("H1 2021"), DDC achieved RMB 88.1 million (or approximately USD 13.6 million) in revenue. DDC, has and continues to focus on improving the overall cost structure of the business. As a result, for H1 2021, its gross profit margin was 21.6% (versus 15.7% for the six month period ended June 30, 2020).

    Independent Directors and Advisor

    In addition, DDC announced today the appointment of three new Independent Directors to its Board of Directors Conor Chia-Hung Yang, Matthew Gene Mouw, and Sam Shih. In addition, DDC appointed a new advisor, Dr. Malik Sadiq, to its Advisory Board.

    DDC Founder and CEO, Norma Chu, commented, "Conor, Matthew, Sam, and Malik are all experienced and respected veterans of this field who will be instrumental in propelling our company to the next level and unlocking additional growth opportunities as we shape DDC's future strategic direction. Each brings invaluable industry insights, product innovation, execution, and management excellence to our team and we look forward to benefitting from their collaboration."

    Mr. Conor Chia-Hung Yang is an experienced CFO who has brought Chinese TMT companies to successful US listings. He is an experienced audit committee chair for a number of US listed companies, including EHang (NASDAQ:EH) and I-Mab (NASDAQ:IMAB). Mr. Yang is a co-founder of Black Fish Technology Group Limited ("Black Fish"), and served as its president from November 2017 to February 2021. Prior to joining Black Fish, Mr. Yang was the Chief Financial Officer of Tuniu Corporation (NASDAQ:TOUR) from January 2013 to November 2017.

    Mr. Sam Shih has more than 30 years of corporate experience in China and Asia Pacific regions, having extensive experience with PepsiCo Inc. ("PepsiCo") and Redbull. Mr. Shih is currently a partner and Chief Operating Officer of OYO Hotel Company, an unicorn start-up backed by Softbank in China since 2018. Mr. Shih started his career and spent over two decades with PepsiCo. During his tenure with PepsiCo, he held various senior positions, such as Chief Executive Officer of PepsiCo Investment (China) Limited, and Vice President of Pepsi Beverage Business in China.

    Mr. Matthew Gene Mouw has accumulated extensive experience in general management, sales & marketing, international expansion, and M&A with global food brands during his career. Mr. Mouw served as Regional President Asia, Africa and Australia for Barilla SpA from March 2011 to December 2015. Prior to that, Mr. Mouw held various senior positions at Groupe Danone, including General Manager for Danone SA in China, General Representative of Robust China Co., Ltd., General Manager of Danone (Health Mineral Water) and General Manager of Danone (Home and Delivery) from September 2000 to September 2010.

    Dr. Malik Sadiq has more than 25 years of experience in the food and strategy consulting industry across China, India, and the US. Dr. Sadiq is currently the Chief Operating Officer of LIVEKINDLY Co. ("LIVEKINDLY"). Prior to his role with LIVEKINDLY, Dr. Sadiq worked in Tyson Foods, holding several senior management positions since May 2007, including CEO India, COO China, and Head of Global Sourcing and Business Optimization. Dr. Sadiq also served as the Vice President of Consumer Practice at Hitachi Consulting from July 2002 to May 2006. Dr Sadiq holds a Master of Science in Industrial Engineering and a PHD in industrial Engineering from University of Arkansas.

    About DDC

    DDC is a private company incorporated in the British Virgin Islands in 2012, which started its business in Hong Kong and expanded its business to Shanghai, PRC in 2015, whereupon it registered by the way of continuation in the Cayman Islands in the same year. The Group is a digital publisher and merchandiser for Asian cooking based in Hong Kong and Mainland China. The Group mainly runs the leading content-driven lifestyle brand, DayDayCook for young food lovers who are seeking quality food and convenience from ready-to-heat (RTH), ready-to-cook (RTC) and plant-based food products. An omni-channel approach is adopted by the Group to promote and sell their products, including online, offline and social commerce channels. The Group also continuously builds brand recognition and fan base through online video contents, such as recipe video, product evaluation, live streaming and advertising videos.

    About Ace Global Business Acquisition Limited

    Ace is a British Virgin Islands company incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

    Forward-Looking Statements

    This press release contains, and certain oral statements made by representatives of Ace, DDC, and their respective affiliates, from time to time may contain, "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Ace's and DDC's actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "might" and "continues," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Ace's and DDC's expectations with respect to future performance and anticipated financial impacts of the Business Combination, the satisfaction of the closing conditions to the Business Combination and the timing of the completion of the Business Combination. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside the control of Ace or DDC and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive share exchange agreement (the "Merger Agreement") relating to the proposed Business Combination; (2) the outcome of any legal proceedings that may be instituted against Ace or DDC following the announcement of the Merger Agreement and the transactions contemplated therein; (3) the inability to complete the Business Combination, including due to failure to obtain approval of the shareholders of Ace or other conditions to closing in the Merger Agreement; (4) delays in obtaining or the inability to obtain necessary regulatory approvals (including approval from insurance regulators) required to complete the transactions contemplated by the Merger Agreement; (5) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement or could otherwise cause the transaction to fail to close; (6) the inability to obtain or maintain the listing of the post-acquisition company's ordinary shares on NASDAQ following the Business Combination; (7) the risk that the Business Combination disrupts current plans and operations as a result of the announcement and consummation of the Business Combination; (8) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably and retain its key employees; (9) costs related to the Business Combination; (10) changes in applicable laws or regulations; (11) the possibility that DDC or the combined company may be adversely affected by other economic, business, and/or competitive factors; and (12) other risks and uncertainties to be identified by Ace in the preliminary proxy statement relating to the Business Combination, including those under "Risk Factors" therein, and in other filings with the SEC made by Ace and DDC. Ace and DDC caution that the foregoing list of factors is not exclusive. Ace and DDC caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Neither Ace nor DDC undertakes or accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

    Important Information

    In connection with the transaction described herein, Ace will file relevant materials with the SEC including a preliminary proxy statement on Schedule 14A filed on November 5, 2021 with the SEC, and a definitive proxy statement on Schedule 14A, when available. Ace's shareholders and other interested persons are advised to read the preliminary proxy statement and the amendments (if any) thereto and, when available, the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed Business Combination, as these materials will contain material information about DDC, Ace, and the proposed Business Combination. Promptly after filing its definitive proxy statement relating to the proposed Business Combination with SEC and the registration statement is declared effective, Ace will mail the proxy statement/prospectus and a proxy card to each stockholder entitled to vote at the special meeting relating to the transaction. INVESTORS AND SECURITY HOLDERS OF ACE ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTION THAT ACE WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT DDC, ACE AND THE PROPOSED BUSINESS COMBINATION. The proxy statement/prospectus and other relevant materials in connection with the transaction (when they become available), and any other documents filed by Ace with the SEC, may be obtained free of charge at the SEC's website (www.sec.gov).

    Participants in the Solicitation

    Ace and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders of Ace ordinary shares in respect of the proposed transaction described herein. Information about Ace's directors and executive officers and their ownership of Ace's ordinary shares is set forth in Ace's Annual Report on Form 10-K filed with the SEC, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. These documents can be obtained free of charge from the sources indicated below.

    DDC and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Ace in connection with the proposed Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed Business Combination is included in the preliminary proxy statement for the proposed Business Combination.

    No Offer or Solicitation

    This press release shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the proposed Business Combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

    Contacts

    For Ace Global Business Acquisition Limited:

    Eugene Wong, CEO

    [email protected]

    +852 9086 7042

    For DDC Enterprise Limited:

    Norma Chu, Founder & CEO

    [email protected]

    SOURCE Ace Global Business Acquisition Limited



    Get the next $ACBA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACBA
    $EH
    $IMAB
    $TOUR

    CompanyDatePrice TargetRatingAnalyst
    EHang Holdings Limited
    $EH
    5/5/2025$30.40Buy
    Jefferies
    EHang Holdings Limited
    $EH
    4/14/2025$20.00Hold → Buy
    Deutsche Bank
    EHang Holdings Limited
    $EH
    4/2/2025$30.00Buy
    Daiwa Securities
    EHang Holdings Limited
    $EH
    9/24/2024Buy
    China Renaissance
    EHang Holdings Limited
    $EH
    8/28/2024$22.00Buy
    UBS
    EHang Holdings Limited
    $EH
    5/6/2024$27.50Overweight
    Morgan Stanley
    EHang Holdings Limited
    $EH
    10/16/2023$30.50Neutral → Buy
    Goldman
    EHang Holdings Limited
    $EH
    10/27/2022$4.00Neutral
    Goldman
    More analyst ratings

    $ACBA
    $EH
    $IMAB
    $TOUR
    Leadership Updates

    Live Leadership Updates

    See more
    • I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

      Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025Enrollment completed ahead of schedule in the first givastomig Phase 1b dose expansion cohort; momentum continues in the second expansion cohortStrong financial position supported by $173.4 million of cash and cash equivalents, and short-term investments as of December 31, 2024; provides runway into 2027, through expected clinical readouts for givastomig ROCKVILLE, Md., April 03, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology

      4/3/25 4:01:00 PM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

      Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritizationThe Company has completed enrollment of a dose escalation study of givastomig in combination with nivolumab plus chemotherapy, and data is expected in the early second half of 2025; a 40-patient dose expansion study is now underway with data expected in early 2026Cash balance of $184.4 million (as of September 30, 2024), expected to support operations into 2027, complemented by a strengthened U.S.-based leadership team and streamlined operating modelROCKVILLE, MD, Jan. 6, 2025 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based,

      1/6/25 7:00:00 AM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • I-Mab Reports Third Quarter 2024 Results

      Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy dataOn track to dose first patient in randomized Phase 2 study of uliledlimab in first-line mNSCLC in 1H 2025Appointed Dr. Sean Fu as permanent CEO effective November 1, 2024Estimated cash runway into 2027, based on $184.4 million in cash and cash equivalents, and short-term investments as of September 30, 2024ROCKVILLE, Md., Nov. 14, 2024 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced financial results for the three and nine months ended

      11/14/24 7:00:00 AM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ACBA
    $EH
    $IMAB
    $TOUR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

      ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that an abstract for a combination study of givastomig plus nivolumab and chemotherapy has been accepted for a mini-oral presentation at the ESMO Gastrointestinal Cancers Congress 2025, which will be held July 2-5 in Barcelona, Spain. "We are very pleased to receive confirmation that new clinical data for givastomig has been accepted as an oral presentation at the upcoming ESMO Gastrointestinal Cancers Congress 2025. As more information becomes available fr

      4/30/25 7:00:00 AM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Tuniu Corporation Files Its Annual Report on Form 20-F

      NANJING, China, April 17, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission. The annual report can be accessed on the Company's investor relations website at http://ir.tuniu.com or the SEC's website at www.sec.gov. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Investor Relations Department at 12th

      4/17/25 10:10:00 PM ET
      $TOUR
      Transportation Services
      Consumer Discretionary
    • EHang Files Annual Report on Form 20-F for Fiscal Year 2024

      GUANGZHOU, China, April 15, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:EH), the world's leading urban air mobility ("UAM") technology platform company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC") on April 15, 2025. The annual report can be accessed on the Company's investor relations website at http://ir.ehang.com/ and on the SEC's website at https://www.sec.gov/. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holder

      4/15/25 7:36:13 AM ET
      $EH
      Aerospace
      Industrials

    $ACBA
    $EH
    $IMAB
    $TOUR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Tuniu Corporation

      SC 13D/A - Tuniu Corp (0001597095) (Subject)

      12/6/24 6:30:27 AM ET
      $TOUR
      Transportation Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Tuniu Corporation (Amendment)

      SC 13D/A - Tuniu Corp (0001597095) (Subject)

      4/11/24 6:11:21 AM ET
      $TOUR
      Transportation Services
      Consumer Discretionary
    • SEC Form SC 13G filed by EHang Holdings Limited

      SC 13G - EHang Holdings Ltd (0001759783) (Subject)

      3/6/24 5:28:05 PM ET
      $EH
      Aerospace
      Industrials

    $ACBA
    $EH
    $IMAB
    $TOUR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Harraden Circle Investments, Llc sold $605,000 worth of Ordinary Shares (50,000 units at $12.10) (SEC Form 4)

      4 - Ace Global Business Acquisition Ltd (0001844389) (Issuer)

      5/24/24 3:34:23 PM ET
      $ACBA
      Catalog/Specialty Distribution
      Consumer Discretionary
    • New insider Harraden Circle Investments, Llc claimed ownership of 270,214 units of Ordinary Shares (SEC Form 3)

      3 - Ace Global Business Acquisition Ltd (0001844389) (Issuer)

      4/11/24 6:30:05 AM ET
      $ACBA
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Polar Asset Management Partners Inc. disposed of $4,588,479 worth of Ordinary Shares (378,900 units at $12.11) (SEC Form 4)

      4 - Ace Global Business Acquisition Ltd (0001844389) (Issuer)

      4/10/24 6:16:02 AM ET
      $ACBA
      Catalog/Specialty Distribution
      Consumer Discretionary

    $ACBA
    $EH
    $IMAB
    $TOUR
    SEC Filings

    See more
    • SEC Form F-3 filed by I-MAB

      F-3 - I-Mab (0001778016) (Filer)

      5/2/25 5:01:56 PM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by I-MAB

      6-K - I-Mab (0001778016) (Filer)

      4/30/25 7:14:42 AM ET
      $IMAB
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 20-F filed by Tuniu Corporation

      20-F - Tuniu Corp (0001597095) (Filer)

      4/17/25 6:06:40 AM ET
      $TOUR
      Transportation Services
      Consumer Discretionary

    $ACBA
    $EH
    $IMAB
    $TOUR
    Financials

    Live finance-specific insights

    See more
    • Tuniu Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results and Cash Dividend

      NANJING, China, March 14, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Highlights for the Fiscal Year 2024 Revenues from package tours in 2024 increased by 22.2% year-over-year to RMB407.5 million (US$55.8 million[1]).Gross profit in 2024 increased by 21.9% year-over-year to RMB358.0 million (US$ 49.1million).Income from operations was RMB63.3 million (US$8.7 million) in 2024, compared to a loss from operations of RMB101.9 million in 2023. Non-GAAP[2] income from operations was RMB66.9 million (

      3/14/25 6:00:00 AM ET
      $TOUR
      Transportation Services
      Consumer Discretionary
    • EHang Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

      Record-high quarterly and annual revenues, up 190.2% and 288.5% YoY, respectivelyRecord-high quarterly and annual delivery volume, 216 units in 20241st year and 3rd consecutive quarter of non-GAAP profitability11st year and 5th consecutive quarter of positive operating cash flowFiscal year 2025 revenues expected to be around RMB900 million, up 97% YoY GUANGZHOU, China, March 11, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:EH), the world's leading Urban Air Mobility ("UAM") technology platform company, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Operational and Financial High

      3/12/25 2:10:00 AM ET
      $EH
      Aerospace
      Industrials
    • EHang to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on Wednesday, March 12, 2025

      GUANGZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited (NASDAQ:EH) ("EHang" or the "Company"), the world's leading Urban Air Mobility ("UAM") technology platform company, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024 on Wednesday, March 12, 2025, before the U.S. market opens. EHang's management team will host an earnings conference call at 8:00 AM on Wednesday, March 12, 2025, U.S. Eastern Time (8:00 PM on Wednesday, March 12, 2025, Beijing/Hong Kong Time). To join the conference call via telephone, participants must use the following link to complete an online registration

      3/5/25 4:18:12 AM ET
      $EH
      Aerospace
      Industrials

    $ACBA
    $EH
    $IMAB
    $TOUR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on EHang with a new price target

      Jefferies initiated coverage of EHang with a rating of Buy and set a new price target of $30.40

      5/5/25 8:31:06 AM ET
      $EH
      Aerospace
      Industrials
    • EHang upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded EHang from Hold to Buy and set a new price target of $20.00

      4/14/25 8:04:47 AM ET
      $EH
      Aerospace
      Industrials
    • Daiwa Securities initiated coverage on EHang with a new price target

      Daiwa Securities initiated coverage of EHang with a rating of Buy and set a new price target of $30.00

      4/2/25 8:49:58 AM ET
      $EH
      Aerospace
      Industrials